Paul A Friedman's Net Worth

$478 Million

Estimate Recalculated Feb 16, 2024 12:54PM EST

Who is Paul A Friedman?

Paul A Friedman has an estimated net worth of $478 Million. This is based on reported shares across multiple companies, which include MADRIGAL PHARMACEUTICALS, INC., Sirtris Pharmaceuticals, Inc., Prelude Therapeutics Inc, Verastem, Inc., Cerulean Pharma Inc., Durata Therapeutics, Inc., AUXILIUM PHARMACEUTICALS INC, ALEXION PHARMACEUTICALS, INC., BAUSCH & LOMB INC, and INCYTE CORP.

SEC CIK

Paul A Friedman's CIK is 0001236927

Past Insider Trading and Trends

2014 was Paul A Friedman's most active year for acquiring shares with 23 total transactions. Paul A Friedman's most active month to acquire stocks was the month of April. 2015 was Paul A Friedman's most active year for disposing of shares, totalling 33 transactions. Paul A Friedman's most active month to dispose stocks was the month of April. 2015 saw Paul A Friedman paying a total of $8,403,941.68 for 604,520 shares, this is the most they've acquired in one year. In 2014 Paul A Friedman cashed out on 2,052,241 shares for a total of $66,346,814.02, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

MADRIGAL PHARMACEUTICALS, INC. (MDGL) Snapshot price: $187.82

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-10.13%
-2.25K
$243.92
-$549,795.68
20K
Jan 16
Form 4
26.67K
26.67K
Jan 16
Form 4
0
0
Feb 22
Form 4
0
0
Feb 22
Form 4
0
0
Mar 5
Form 4
0
0
Mar 7
Form 4
+2.55%
4K
$117.88
$471,520.00
161.13K
Nov 20
Form 4
+2.61%
4K
$124.00
$496,000.00
157.13K
Nov 19
Form 4
-10.08%
-73.53K
$287.46
-$21,135,783.96
655.54K
Jun 11
Form 4
0
0
Mar 1
Form 4
0
0
Mar 2
Form 4/A
+104,882.19%
153.13K
153.27K
Jul 22
Form 4
872.77K
872.77K
Jul 22
Form 3
0
0
Form 4
6.82K
6.82K
Jul 1
Form 4
0
0
Jul 1
Form 4
0
0
Mar 3
Form 3
0
0
No matching records found

Sirtris Pharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Apr 16
Form 3
0
0
No matching records found

Prelude Therapeutics Inc (PRLD) Snapshot price: $2.92

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 16
Form 4
0
0
Jun 17
Form 4
0
0
Jun 18
Form 4
+866.78%
448.37K
500.1K
Mar 27 - Sep 29
Form 3
0
0
No matching records found

Verastem, Inc. (VSTM) Snapshot price: $14.01

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 14
Form 4
0
0
Jun 12
Form 4
3K
$8.31
$24,932.40
3K
Dec 24
Form 4
0
0
May 12
Form 3
0
0
No matching records found

Cerulean Pharma Inc. (DARE) Snapshot price: $0.3302

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+120.21%
10.27K
$0.73
$7,499.29
18.82K
Apr 3
Form 4
+132.48%
4.87K
$0.77
$3,749.90
8.55K
Jan 3
Form 4
3.68K
$1.02
$3,749.52
3.68K
Oct 3
Form 4
0
0
Jun 22
Form 4
0
0
Jun 26
Form 4
0
0
Oct 29
Form 3
0
0
No matching records found